Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2009

01-08-2009 | Original Article

Evaluation of a new automated, enzymatic inulin assay using d-fructose dehydrogenase

Authors: Shinsuke Kimata, Katsuhiko Mizuguchi, Shizuo Hattori, Shinichi Teshima, Yoshimasa Orita

Published in: Clinical and Experimental Nephrology | Issue 4/2009

Login to get access

Abstract

Background

Inulin clearance (Cin) is widely considered to be a gold-standard assessment of glomerular filtration rate (GFR). Although inulin concentrations are commonly determined by the anthrone method, this method has several disadvantages, including a hazardous heating procedure using a strong acid, as well as a nonspecific reaction and being influenced by other saccharides such as glucose.

Method

Here, we report the development of a new automated, enzymatic inulin assay. This method uses d-fructose dehydrogenase (EC1.1.99.11), which does not require NAD or NADP as the electron acceptor, and utilizes oxygen transfer from hydrogen peroxide to an electron acceptor in a sensitive chromophoric system. This method allows rapid and accurate determination of inulin concentrations, and takes only 15 min on automated analyzers. We evaluated this new assay and compared it with the anthrone method.

Results

The detection limit value and linearity of the new method were 5 mg/l and up to 300 mg/l, respectively. The within-run precision coefficient of variations (CVs) for serum and for urine were 2.05 ± 0.79% (mean ± SEM; n = 3) and 0.92 ± 0.24%, respectively, and the between-run precision CVs for serum and for urine were 1.91 ± 0.72% and 1.86 ± 0.17%, respectively. No influence of glucose was observed with the new method, while a positive influence of 38.7% was observed with the anthrone method. However, neither method was influenced by fructose (3.0 mg/l in serum or 30 mg/l in urine). The analytical recovery rates of inulin were 97.8 ± 0.7% (mean ± SEM; n = 6) in serum and 99.0 ± 0.4% in urine using the enzymatic method. We compared results for the enzymatic method and the anthrone method using 46 serum samples and 46 urine samples. Bland–Altman plots showed no significant difference between the two methods for the serum samples. However, inulin recovery in the urine samples measured by the enzymatic method was about 5% higher than that obtained by the anthrone method.

Conclusion

The new enzymatic assay offers a more convenient and more accurate measurement of inulin and may be suitable for routine procedures by automated analyzers in clinical laboratories.
Literature
1.
go back to reference Smith H. The Kidney: structure and function in health and disease. New York: Oxford University Press; 1951. p. 231–8. Smith H. The Kidney: structure and function in health and disease. New York: Oxford University Press; 1951. p. 231–8.
2.
go back to reference White RP, Samson FE Jr. Determination of inulin in plasma and urine by use of anthrone. J Lab Clin Med. 1954;43:475–8.PubMed White RP, Samson FE Jr. Determination of inulin in plasma and urine by use of anthrone. J Lab Clin Med. 1954;43:475–8.PubMed
3.
go back to reference Soper CP, Bending MR, Barron JL. An automated enzymatic inulin assay, capable of full sinistrin hydrolysis. Eur J Clin Chem Clin Biochem. 1995;33:497–501.PubMed Soper CP, Bending MR, Barron JL. An automated enzymatic inulin assay, capable of full sinistrin hydrolysis. Eur J Clin Chem Clin Biochem. 1995;33:497–501.PubMed
4.
go back to reference Degenaar CP, Frenken LA, von Hooff JP. The enzymatic method for determination of inulin. Clin Chem. 1987;33:1070–1.PubMed Degenaar CP, Frenken LA, von Hooff JP. The enzymatic method for determination of inulin. Clin Chem. 1987;33:1070–1.PubMed
5.
go back to reference Kuehnle HF, von Dahl KV, Schmidt FH. Fully enzymatic inulin determination in small volume samples without deproteinization. Nephron. 1992;62:104–7.CrossRefPubMed Kuehnle HF, von Dahl KV, Schmidt FH. Fully enzymatic inulin determination in small volume samples without deproteinization. Nephron. 1992;62:104–7.CrossRefPubMed
6.
go back to reference Summerfield AL, Hortin GL, Smith CH, Wilhite TR, Landt M. Automated enzymatic analysis of inulin. Clin Chem. 1993;39:2333–7.PubMed Summerfield AL, Hortin GL, Smith CH, Wilhite TR, Landt M. Automated enzymatic analysis of inulin. Clin Chem. 1993;39:2333–7.PubMed
7.
go back to reference Sugita O, Tomiyama Y, Matsuto T, et al. A new enzymatic method for the determination of inulin. Ann Clin Biochem. 1995;32:561–5.CrossRefPubMed Sugita O, Tomiyama Y, Matsuto T, et al. A new enzymatic method for the determination of inulin. Ann Clin Biochem. 1995;32:561–5.CrossRefPubMed
8.
go back to reference Ameyama M, Shinagawa E, Matsushita K, Adachi O. d-Fructose dehydrogenase of Gluconobacter industrius: purification, characterization, and application to enzymatic microdetermination of d-fructose. J Bacteriol. 1981;145:814–23.PubMedPubMedCentral Ameyama M, Shinagawa E, Matsushita K, Adachi O. d-Fructose dehydrogenase of Gluconobacter industrius: purification, characterization, and application to enzymatic microdetermination of d-fructose. J Bacteriol. 1981;145:814–23.PubMedPubMedCentral
9.
go back to reference Kawasaki T, Akanuma H, Yamanouchi T. Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002;25:353–7.CrossRefPubMed Kawasaki T, Akanuma H, Yamanouchi T. Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002;25:353–7.CrossRefPubMed
10.
go back to reference Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–100.CrossRefPubMed Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–100.CrossRefPubMed
Metadata
Title
Evaluation of a new automated, enzymatic inulin assay using d-fructose dehydrogenase
Authors
Shinsuke Kimata
Katsuhiko Mizuguchi
Shizuo Hattori
Shinichi Teshima
Yoshimasa Orita
Publication date
01-08-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0174-6

Other articles of this Issue 4/2009

Clinical and Experimental Nephrology 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine